Literature DB >> 27703678

Mucinous adenocarcinoma of the bladder: A case report and review of the literature.

Xiang Pan1, Lu Jin1, Tao He2, Jia Hu2, Jing Quan1, Lijun Zhou3, Liangchao Ni3, Shangqi Yang3, Xiangming Mao3, Yongqing Lai3.   

Abstract

Mucinous adenocarcinoma of the bladder is rare. The most common symptoms are hematuria, suprapubic pain and dysuria. The patient in the present case was a 59-year-old female who presented with a tumor sized ~5.0×3.4 cm, located in the anterior bladder wall, which was pathologically diagnosed as mucinous bladder adenocarcinoma. The stage at presentation was considered to be advanced and inoperable, due to extensive local invasion. For this type of cancer, early diagnosis is crucial. If the cancer is limited to the bladder, the survival rate may exceed 75%. Thus, for patients with confirmed or highly suspicious bladder mucinous adenocarcinoma, radical bladder cancer resection is required. The 5-year survival rate of this type of cancer is 35-55%. In the present case, the cancer of the patient was considered inoperable and 3 months later she succumbed to the disease.

Entities:  

Keywords:  adenocarcinoma; bladder tumor; mucinous adenocarcinoma of the bladder

Year:  2016        PMID: 27703678      PMCID: PMC5038899          DOI: 10.3892/mco.2016.985

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  12 in total

1.  Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases.

Authors:  A W Bates; S I Baithun
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

2.  Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients.

Authors:  Mohamed S Zaghloul; Akram Nouh; Mohamed Nazmy; Samy Ramzy; Ashraf S Zaghloul; Mohamed Abou Sedira; Ehab Khalil
Journal:  Urol Oncol       Date:  2006 Jan-Feb       Impact factor: 3.498

3.  International variations in bladder cancer incidence and mortality.

Authors:  Saurabh Chavan; Freddie Bray; Joannie Lortet-Tieulent; Michael Goodman; Ahmedin Jemal
Journal:  Eur Urol       Date:  2013-10-16       Impact factor: 20.096

4.  The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract.

Authors:  P S Bullock; D E Thoni; W M Murphy
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

5.  Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.

Authors:  Jonathan L Wright; Michael P Porter; Christopher I Li; Paul H Lange; Daniel W Lin
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860

6.  Mucinous metaplasia in urothelial tract may be the precancerous lesion of mucinous adenocarcinoma: report of two cases and review of literature.

Authors:  Bu-Yi Zhang; Josephine Aguilar; Min Yang; Ping Wang; Baizhou Li
Journal:  Int J Clin Exp Med       Date:  2014-01-15

7.  Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder.

Authors:  A F Kantor; P Hartge; R N Hoover; J F Fraumeni
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

Review 8.  The impact of variant histology on the outcome of bladder cancer treated with curative intent.

Authors:  Peter C Black; Gordon A Brown; Colin P N Dinney
Journal:  Urol Oncol       Date:  2008-01-14       Impact factor: 3.498

Review 9.  Signet-ring cell adenocarcinoma of bladder.

Authors:  L Fiter; F Gimeno; L Martin; L Gómez Tejeda
Journal:  Urology       Date:  1993-01       Impact factor: 2.649

10.  Mucinous adenocarcinoma of the urinary bladder.

Authors:  Giulio Baffigo; Giampaolo Delicato; Daniele Bianchi; Stefano Signore; Edoardo Tartaglia; Francesco Corvese; Alessandro Perla; Bonaventura Marino; Giuseppe Santeusanio; Vincenzo Ferdinandi
Journal:  Am J Case Rep       Date:  2012-06-05
View more
  1 in total

1.  Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review.

Authors:  Dawei Wang; Keping Zhang; Lihui Guan; Nuan Wen
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.